| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell and Tumor Biology |
Departments of 1 Urology, 2 Cell Biology and Anatomy, and 3 Radiation Oncology and 4 Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida
Requests for reprints: Vinata B. Lokeshwar, Department of Urology (M-800), University of Miami School of Medicine, P.O. Box 016960, Miami, FL 33101. Phone: 305-243-6321; Fax: 305-243-6893; E-mail: vlokeshw{at}med.miami.edu.
Hyaluronic acid and HYAL1-type hyaluronidase show high accuracy in detecting bladder cancer and evaluating its grade, respectively. Hyaluronic acid promotes tumor progression; however, the functions of hyaluronidase in cancer are largely unknown. In this study, we stably transfected HT1376 bladder cancer cells with HYAL1-sense (HYAL1-S), HYAL1-antisense (HYAL1-AS), or vector cDNA constructs. Whereas HYAL1-S transfectants produced 3-fold more HYAL1 than vector transfectants, HYAL1-AS transfectants showed 
90% reduction in HYAL1 production. HYAL1-AS transfectants grew four times slower than vector and HYAL1-S transfectants and were blocked in the G2-M phase of the cell cycle. The expression of cdc25c and cyclin B1 and cdc2/p34-associated H1 histone kinase activity also decreased in HYAL1-AS transfectants. HYAL1-S transfectants were 30% to 44% more invasive, and HYAL1-AS transfectants were 50% less invasive than the vector transfectants in vitro. In xenografts, there was a 4- to 5-fold delay in the generation of palpable HYAL1-AS tumors, and the weight of HYAL1-AS tumors was 9- to 17-fold less than vector and HYAL1-S tumors, respectively (P < 0.001). Whereas HYAL1-S and vector tumors infiltrated skeletal muscle and blood vessels, HYAL1-AS tumors resembled benign neoplasia. HYAL1-S and vector tumors expressed significantly higher amounts of HYAL1 (in tumor cells) and hyaluronic acid (in tumor-associated stroma) than HYAL1-AS tumors. Microvessel density in HYAL1-S tumors was 3.8- and 9.5-fold higher than that in vector and HYAL1-AS tumors, respectively. These results show that HYAL1 expression in bladder cancer cells regulates tumor growth and progression and therefore serves as a marker for high-grade bladder cancer.
Key Words: Bladder cancer • HyaluronidaseHYAL1 • tumor growth • tumor invasion • angiogenesis
This article has been cited by other articles:
|
|
 |
|
  K. N. Sugahara, T. Hirata, T. Tanaka, S. Ogino, M. Takeda, H. Terasawa, I. Shimada, J.-i. Tamura, G. B. ten Dam, T. H. van Kuppevelt, et al. Chondroitin Sulfate E Fragments Enhance CD44 Cleavage and CD44-Dependent Motility in Tumor Cells Cancer Res., September 1, 2008; 68(17): 7191 - 7199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Poola, J. Abraham, J. J. Marshalleck, Q. Yue, V. B. Lokeshwar, G. Bonney, and R. L. DeWitty Molecular Risk Assessment for Breast Cancer Development in Patients with Ductal Hyperplasias Clin. Cancer Res., February 15, 2008; 14(4): 1274 - 1280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Golshani, L. Lopez, V. Estrella, M. Kramer, N. Iida, and V. B. Lokeshwar Hyaluronic Acid Synthase-1 Expression Regulates Bladder Cancer Growth, Invasion, and Angiogenesis through CD44 Cancer Res., January 15, 2008; 68(2): 483 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. Bharadwaj, K. Rector, and M. A. Simpson Inducible Hyaluronan Production Reveals Differential Effects on Prostate Tumor Cell Growth and Tumor Angiogenesis J. Biol. Chem., July 13, 2007; 282(28): 20561 - 20572. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S.A. Hofinger, M. Spickenreither, J. Oschmann, G. Bernhardt, R. Rudolph, and A. Buschauer Recombinant human hyaluronidase Hyal-1: insect cells versus Escherichia coli as expression system and identification of low molecular weight inhibitors Glycobiology, April 1, 2007; 17(4): 444 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Harada and M. Takahashi CD44-dependent Intracellular and Extracellular Catabolism of Hyaluronic Acid by Hyaluronidase-1 and -2 J. Biol. Chem., February 23, 2007; 282(8): 5597 - 5607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Black, G. A. Brown, and C. P. Dinney Molecular Markers of Urothelial Cancer and Their Use in the Monitoring of Superficial Urothelial Cancer J. Clin. Oncol., December 10, 2006; 24(35): 5528 - 5535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. B. Lokeshwar, V. Estrella, L. Lopez, M. Kramer, P. Gomez, M. S. Soloway, and B. L. Lokeshwar HYAL1-v1, An Alternatively Spliced Variant of HYAL1 Hyaluronidase: A Negative Regulator of Bladder Cancer Cancer Res., December 1, 2006; 66(23): 11219 - 11227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Was, T. Cichon, R. Smolarczyk, D. Rudnicka, M. Stopa, C. Chevalier, J. J. Leger, B. Lackowska, A. Grochot, K. Bojkowska, et al. Overexpression of Heme Oxygenase-1 in Murine Melanoma: Increased Proliferation and Viability of Tumor Cells, Decreased Survival of Mice Am. J. Pathol., December 1, 2006; 169(6): 2181 - 2198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. W. Yip, M. Smollich, and M. Gotte Therapeutic value of glycosaminoglycans in cancer. Mol. Cancer Ther., September 1, 2006; 5(9): 2139 - 2148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Cao, R. C. Savani, M. Fehrenbach, C. Lyons, L. Zhang, G. Coukos, and H. M. DeLisser Involvement of Endothelial CD44 during in Vivo Angiogenesis Am. J. Pathol., July 1, 2006; 169(1): 325 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Isoyama, D. Thwaites, M. G. Selzer, R. I. Carey, R. Barbucci, and V. B. Lokeshwar Differential selectivity of hyaluronidase inhibitors toward acidic and basic hyaluronidases Glycobiology, January 1, 2006; 16(1): 11 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. B. Lokeshwar, W. H. Cerwinka, T. Isoyama, and B. L. Lokeshwar HYAL1 Hyaluronidase in Prostate Cancer: A Tumor Promoter and Suppressor Cancer Res., September 1, 2005; 65(17): 7782 - 7789. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
